Skip to main content

Advertisement

Table 1 Characteristics of participants in the BC HIV/AIDS Drug Treatment Program by era of HAART initiation

From: Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study

ERA (n) 1996-98
(967)
1999-01
(897)
2002-04
(783)
2005-07
(1074)
p-value
N (%) Male 829(85.7) 694(77.4) 630(80.5) 863(80.4) < 0.001
N (%) with history of ever using injection drugs 387(40) 341(38) 305(39) 423(39.4) 0.842
Median age (IQR) 37 (32-43) 38 (33-45) 42 (35-48) 42 (36-49) < 0.001
Median CD4 cell count
(IQR)
280
(120-430)
190
(80-330)
150
(70-230)
180
(100-250)
< 0.001